Display options
Share it on

Biomol Ther (Seoul). 2017 Jul 01;25(4):441-451. doi: 10.4062/biomolther.2017.082.

Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters.

Biomolecules & therapeutics

Temdara Tun, Young-Sook Kang

Affiliations

  1. College of Pharmacy, Drug Information Research Institute and Research Center for Cell Fate Control, Sookmyung Women's University, Seoul 04310, Republic of Korea.

PMID: 28554202 PMCID: PMC5499624 DOI: 10.4062/biomolther.2017.082

Abstract

Imperatorin, a major bioactive furanocoumarin with multifunctions, can be used for treating neurodegenerative diseases. In this study, we investigated the characteristics of imperatorin transport in the brain. Experiments of the present study were designed to study imperatorin transport across the blood-brain barrier both

Keywords: Alzheimer's disease; Blood-brain barrier; Imperatorin; Proton coupled antiporter

References

  1. Pharm Res. 2016 Jul;33(7):1711-22 - PubMed
  2. J Pharm Sci. 2014 Oct;103(10):3335-41 - PubMed
  3. Am J Physiol Cell Physiol. 2007 Nov;293(5):C1437-44 - PubMed
  4. AAPS J. 2013 Apr;15(2):299-307 - PubMed
  5. Drug Metab Dispos. 2008 Oct;36(10):2005-13 - PubMed
  6. J Pharmacol Exp Ther. 2009 Apr;329(1):87-93 - PubMed
  7. J Pharm Sci. 2011 Sep;100(9):3912-23 - PubMed
  8. Fitoterapia. 2013 Mar;85:144-53 - PubMed
  9. Pharm Res. 2013 Mar;30(3):847-56 - PubMed
  10. Mol Pharm. 2004 Jan 12;1(1):57-66 - PubMed
  11. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):null - PubMed
  12. Phytochem Rev. 2016;15:627-649 - PubMed
  13. J Pharm Sci. 2011 Sep;100(9):3924-38 - PubMed
  14. J Pharm Pharmacol. 2013 Feb;65(2):171-80 - PubMed
  15. Adv Exp Med Biol. 2000;483:321-4 - PubMed
  16. J Pharm Sci. 2011 Sep;100(9):3773-82 - PubMed
  17. J Neurochem. 2001 Dec;79(5):959-69 - PubMed
  18. Pharm Res. 2007 Jul;24(7):1227-51 - PubMed
  19. Biochem Pharmacol. 2008 May 1;75(9):1689-96 - PubMed
  20. Arch Pharm Res. 2005 Apr;28(4):443-50 - PubMed
  21. J Pharm Pharmacol. 2001 Aug;53(8):1163-8 - PubMed
  22. Exp Clin Psychopharmacol. 2012 Aug;20(4):325-32 - PubMed
  23. Z Naturforsch C. 2007 Sep-Oct;62(9-10):689-93 - PubMed
  24. Br J Pharmacol. 2012 Mar;165(5):1260-87 - PubMed
  25. J Neurochem. 2002 Dec;83(5):1188-95 - PubMed
  26. Br J Pharmacol. 2015 Oct;172(20):4888-904 - PubMed
  27. J Neurochem. 2004 Aug;90(4):931-41 - PubMed
  28. Life Sci. 2000;66(7):649-62 - PubMed
  29. J Cereb Blood Flow Metab. 2009 Jul;29(7):1293-304 - PubMed
  30. Drug Metab Dispos. 2006 Nov;34(11):1868-74 - PubMed
  31. Am J Physiol. 1984 Sep;247(3 Pt 2):H484-93 - PubMed
  32. Phytother Res. 2005 Nov;19(11):938-41 - PubMed
  33. Biol Pharm Bull. 2001 Feb;24(2):111-8 - PubMed
  34. Arch Pharm Res. 2002 Dec;25(6):856-9 - PubMed
  35. Drug Metab Dispos. 2006 Aug;34(8):1423-31 - PubMed
  36. Pharm Res. 1994 May;11(5):738-46 - PubMed
  37. Pharm Res. 1999 Mar;16(3):415-9 - PubMed
  38. Psychopharmacology (Berl). 2015 Mar;232(5):931-42 - PubMed
  39. Cancer Chemother Pharmacol. 2014 May;73(5):1041-5 - PubMed
  40. J Biol Chem. 2004 Sep 3;279(36):37349-59 - PubMed
  41. J Neurochem. 2008 Jan;104(1):113-23 - PubMed
  42. Pharm Res. 2007 Sep;24(9):1745-58 - PubMed
  43. Neurochem Int. 2013 Jan;62(2):173-81 - PubMed
  44. Biol Pharm Bull. 2002 Oct;25(10):1351-5 - PubMed
  45. Fluids Barriers CNS. 2013 Jan 26;10(1):8 - PubMed
  46. Drug Metab Dispos. 1997 Jun;25(6):768-71 - PubMed
  47. Arch Pharm Res. 2000 Oct;23(5):467-70 - PubMed
  48. Korean J Physiol Pharmacol. 2016 Jul;20(4):399-406 - PubMed

Publication Types